Vireo Growth (VREOF) Goodwill (2020 - 2026)

Vireo Growth (VREOF) posted Goodwill of $123.8 million for Q1 2026, up 41.49% sequentially from $87.5 million in Q4 2025.

Vireo Growth (VREOF) Goodwill (2020 - 2026) Analysis & Trends

Vireo Growth has reported Goodwill for 6 years, with the latest figure at $123.8 million in Q1 2026.

Quarterly Goodwill changed N/A year-over-year to $123.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.8 million (changed N/A YoY) and the FY2025 annual result came in at $87.5 million, changed N/A from the prior year.
Goodwill advanced to $123.8 million in Q1 2026 per VREOF's latest filing, from $87.5 million in the prior quarter.
Over five years, Goodwill peaked at $123.8 million in Q1 2026 and troughed at $183836.0 in Q1 2022.
A 4-year average of $38.5 million and a median of $1.6 million in 2022 frame the typical range for Goodwill.
The widest YoY moves for Goodwill: up 1503.96% in 2022, down 94.13% in 2022.
Over 4 years, Goodwill stood at $183836.0 in 2022, then changed by 0.0% to $183836.0 in 2023, then soared by 47496.77% to $87.5 million in 2025, then surged by 41.49% to $123.8 million in 2026.
According to Business Quant data, Goodwill over the past three periods registered $123.8 million, $87.5 million, and $97.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-
2	Teva Pharmaceutical Industries	43.42 Bn	39.76 Bn	2.15 Bn
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.77 Bn	22.98 Bn	5.10 Bn
5	United Therapeutics	22.29 Bn	19.63 Bn	683.80 Mn
6	Viatris	18.78 Bn	17.89 Bn	1.46 Bn
7	Neurocrine Biosciences	15.66 Bn	15.27 Bn	935.80 Mn
8	Elanco Animal Health	11.91 Bn	11.38 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-
10	Vireo Growth	491.44 Mn	349.14 Mn	95.30 Mn

Download Data